Nautilus Biotechnology
Nautilus Biotechnology is a biomedical research company delivering a high-throughput, low-cost platform for analyzing quantifying the human proteome.

Year Established: 2016
Stock Ticker: NAUT
Exchange: NASDAQ
Nautilus Biotechnology is a biomedical research company delivering a high-throughput, low-cost platform for analyzing quantifying the human proteome.
Nautilus Biotechnology is a biomedical research company delivering a high-throughput, low-cost platform for analyzing quantifying the human proteome.
Nautilus Biotechnology is a biomedical research company delivering a high-throughput, low-cost platform for analyzing quantifying the human proteome.
Nautilus Biotechnology is a biomedical research company delivering a high-throughput, low-cost platform for analyzing quantifying the human proteome.